z-logo
open-access-imgOpen Access
PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibition and Stroke Prevention
Author(s) -
Mark J. Alberts,
Paul M. Thompson
Publication year - 2020
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.120.028567
Subject(s) - subtilisin , kexin , pcsk9 , medicine , proprotein convertase , stroke (engine) , evolocumab , cholesterol , lipoprotein , ldl receptor , mechanical engineering , biochemistry , chemistry , engineering , enzyme , apolipoprotein a1

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom